(for every order > 35€)
This 11th edition of the summarized proceedings of the 1998 Eurocancer Days presents a wide-ranging update on the following subjects:
• The most significant advances in the clinical field: in situ canalar breast cancer (questioning the doctrine that estrogen should not be prescribed after breast cancer); significant advances in the treatment of intestinal and bronchial cancers, ovarian adenocarcinomas, and melanomas; the current state of intensive therapy; and present and future radiotherapy procedures.
• The most up-to-date research in fundamental and clinical oncology; re-evaluation of the role of viruses in carcinogenesis; molecular epidemiology; and genetic therapy.
• The increasing attention being paid to alleviating symptoms and complications following treatment, in cases including induced menopause, pain control and caring for terminal patients.
• The collaboration with the Cancerology Forum has pooled knowledge about somatic mutations and the stability of the genome, the cellular cycle, detection and quantification of residual disease, and mata-analyses.